Merck KGaA (MRCG)

160.00
-3.00(-1.84%)
  • Volume:
    4,328
  • Bid/Ask:
    159.80/161.35
  • Day's Range:
    157.10 - 163.00
  • Type:Equity
  • Market:Germany
  • ISIN:DE0006599905
  • WKN:659990

MRCG Overview

Prev. Close
163
Day's Range
157.1-163
Revenue
20.25B
Open
163
52 wk Range
153.2-231.3
EPS
7.33
Volume
4,328
Market Cap
69.88B
Dividend (Yield)
1.85
(1.13%)
Average Vol. (3m)
4,995
P/E Ratio
22.32
Beta
0.59
1-Year Change
2.26%
Shares Outstanding
434,777,878
Next Earnings Date
Aug 04, 2022
What is your sentiment on Merck?
or
Vote to see community's results!

Merck KGaA News

Merck KGaA Analysis

Merck KGaA Company Profile

Merck KGaA Company Profile

Employees
60334
Market
Germany

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Read More

Technical Summary

Type
Daily
Weekly
Monthly
Moving AveragesStrong SellStrong SellNeutral
Technical IndicatorsStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellSell
  • target price 270€ according to zone bourse
    1
    • New pills against COVID-19
      0
      • BREAKING: President Biden will announce Tuesday that pharmaceutical giant Merck will help make JohnsonandJohnson’s single-shot coronavirus vaccine.
        2
        • Short Merck enter now stop loss 98.50 take profit, take profit 86 per 10 cfd
          2
          • Buy it Target 5000/-
            0
            • Buy it Target 5000/-
              0
              • best price to buy ?
                0
                • Target 4250/-
                  0
                  • downtrend triangle at 74
                    2